Erlotinib (Tarceva)
Erlotinib, also known as Tarceva, is a targeted cancer drug used to treat metastatic non-small cell lung cancer (NSCLC) in patients with a specific gene mutation (EGFR exon 19 deletion or exon 21 [L858R] substitution mutations) as first-line therapy, maintenance
Enzalutamide (Xtandi)
Enzalutamide (pronounced [en za LOO ta mide]) is also known by the brand name, Xtandi. It is currently only available as the brand, Xtandi, and there is no generic available. Xtandi is an antineoplastic (anti-cancer) drug that belongs to a
Fulvestrant (Faslodex)
Fulvestrant (pronounced [fool VES trant]) is also known by the brand name, Faslodex. It is an antineoplastic (anti-cancer) drug that belongs to a class called estrogen receptor antagonists. It is an injectable solution that is used to treat locally advanced